Compare · ELV vs OSCR
ELV vs OSCR
Side-by-side comparison of Elevance Health Inc. (ELV) and Oscar Health Inc. (OSCR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and OSCR operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $86.50B, about 9.1x OSCR ($9.55B).
- OSCR has hit the wire 8 times in the past 4 weeks while ELV has been quiet.
- OSCR has more recent analyst coverage (25 ratings vs 23 for ELV).
- Company
- Elevance Health Inc.
- Oscar Health Inc.
- Price
- -
- -
- Market cap
- $86.50B
- $9.55B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 0
- 8
- Recent ratings
- 23
- 25
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Oscar Health Inc.
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a full stack technology platform. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was founded in 2012 and is headquartered in New York, New York.
Latest ELV
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
- Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
- New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
- Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
Latest OSCR
- Chief Financial Officer Blackley Richard Scott sold $595,125 worth of shares (18,750 units at $31.74) (SEC Form 4)
- SEC Form 144 filed by Oscar Health Inc.
- SEC Form 144 filed by Oscar Health Inc.
- SEC Form 144 filed by Oscar Health Inc.
- SEC Form 144 filed by Oscar Health Inc.
- SEC Form 144 filed by Oscar Health Inc.
- Oscar Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 Outlook
- Oscar Health, Inc. to Host 2026 Investor Day
- SEC Form 4 filed by Director Gassen William